Hongene is thrilled to announce our participation in N1C Annual Meeting 2025. Founded in 2021 as a non-profit, the N=1 Collaborative is dedicated to advancing the development of individualized medicines for ultra-rare diseases through a global collaborative platform for knowledge and data sharing. The annual meeting will serve as a forum for dialogue, information transfer and building of collaborative relationships among industry, academia, health authorities and families.
Welcome to visit us at site. Let’s discuss how Hongene’s high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.